TherapeuticsMD, Inc. logo

TherapeuticsMD, Inc. (29TA)

Market Closed
16 Jul, 20:00
XDUS XDUS
1. 75
+0.12
+7.362%
- Market Cap
- P/E Ratio
- Div Yield
0 Volume
- Eps
1.63
Previous Close
Add Transaction
Day Range
1.61 1.75
Year Range
1.32 2.32
Want to track 29TA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

29TA closed yesterday higher at €1.75, an increase of 7.362% from Wednesday's close, completing a monthly decrease of -5.914% or -€0.11. Over the past 12 months, 29TA stock gained 32.5758%.
29TA pays dividends to its shareholders, with the most recent payment made on Jun 10, 2008. The next estimated payment will be in 10 Jun 2008 on Jun 10, 2008 for a total of €13.3333.
The last earnings report, released on May 18, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
TherapeuticsMD, Inc. has completed 3 stock splits, with the recent split occurring on May 09, 2022.
The company's stock is traded on 4 different exchanges and in various currencies, with the primary listing on NASDAQ (NGS) (USD).

29TA Chart

TherapeuticsMD And 2 Other Stocks Under $2 Executives Are Buying

TherapeuticsMD And 2 Other Stocks Under $2 Executives Are Buying

The Dow Jones index closed higher by more than 450 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects.

Benzinga | 1 year ago

TherapeuticsMD, Inc. (29TA) FAQ

What is the stock price today?

The current price is €1.75.

On which exchange is it traded?

TherapeuticsMD, Inc. is listed on XDUS.

What is its stock symbol?

The ticker symbol is 29TA.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has TherapeuticsMD, Inc. ever had a stock split?

TherapeuticsMD, Inc. had 3 splits and the recent split was on May 09, 2022.

TherapeuticsMD, Inc. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Marlan D. Walker CEO
XDUS Exchange
US88338N2062 ISIN
US Country
1 Employees
- Last Dividend
9 May 2022 Last Split
11 Dec 2003 IPO Date

Overview

TherapeuticsMD, Inc. is a prominent pharmaceutical company based in the United States, specifically headquartered in Boca Raton, Florida. Founded in the year 2008, the company has carved a niche for itself in the pharmaceutical industry, principally focusing on the development and commercialization of innovative prescription pharmaceutical and prenatal vitamin products. It has entered into a significant license agreement with Mayne Pharma, empowering TherapeuticsMD to commercialize a unique range of products including IMVEXXY, BIJUVA, and ANNOVERA. Primarily catering to the wholesale distributors and retail pharmacy distributors, TherapeuticsMD has established itself as a key player in its domain, leveraging its strategic partnerships and extensive product range to meet the diverse needs of patients across the United States.

Products and Services

  • IMVEXXY

    IMVEXXY is a distinctive product from TherapeuticsMD's portfolio, designed to address specific health concerns. Its formulation is aimed at providing relief and therapeutic benefits, marking it as a crucial offering in their lineup. Through its distribution, IMVEXXY caters to a specific segment of the pharmaceutical market, reflecting the company's commitment to addressing niche healthcare needs.

  • BIJUVA

    BIJUVA represents another key product under TherapeuticsMD's umbrella, highlighting their focus on innovation and patient-centered solutions. This product is tailored to offer unique benefits, aligning with the company's vision of bringing forward pharmaceutical products that significantly improve patient outcomes. BIJUVA, like the rest of their products, is distributed through a network of wholesale and retail pharmacy distributors, ensuring broad accessibility.

  • ANNOVERA

    ANNOVERA stands out as a testament to TherapeuticsMD's continuous effort in pioneering healthcare solutions. Designed with precision, ANNOVERA is geared towards meeting the evolving needs of patients, thereby solidifying the company's position in the pharmaceutical sector. Its contribution to the company's product line is significant, underpinning TherapeuticsMD's role in leading through innovation.

  • Prenatal Vitamin Products

    The BocaGreenMD and vitaMedMD brands under TherapeuticsMD encapsulate a range of prescription prenatal vitamin products, addressing the critical nutritional needs during pregnancy. These brands are a reflection of TherapeuticsMD’s commitment to maternal and fetal health, providing comprehensive nutritional support through scientifically-formulated products. Distributed widely, these prenatal vitamins play a pivotal role in the company's mission to enhance healthcare outcomes.

Contact Information

Address: 951 Yamato Road
Phone: 561 961 1900